Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Trabodenoson (INO-8875) 是一种具有选择性和有效性的的腺苷 A1 受体激动剂,是一种腺苷类似物,可用于研究原发性开角型青光眼。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 3,290 | 现货 | ||
10 mg | ¥ 4,730 | 现货 | ||
25 mg | ¥ 7,260 | 现货 | ||
50 mg | ¥ 9,790 | 现货 | ||
100 mg | ¥ 13,200 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 3,650 | 现货 |
产品描述 | Trabodenoson (INO-8875) is a selective and potent adenosine A1 receptor agonist, an adenosine analog, for the study of primary open-angle glaucoma. |
体外活性 | Treatment with Trabodenoson significantly increases MMP-2 activity and MMP-14 abundance, while decreasing expression of fibronectin and collagen IV[2]. |
体内活性 |
Trabodenoson (6.0%) demonstrates an average IOP drop of 2.45 ± 0.38 mm Hg in young mice over 7 days (downregulation)[2]. In induced eyes, topical trabodenoson significantly upregulates nestin expression in the ONH compared with vehicle-treated non-induced eyes[1]. Trabodenoson-treated eyes show significantly reduced optic nerve (ON) edema compared with vehicle-treated eyes. Additionally, RGC counts are higher in Trabodenoson-treated eyes compared to vehicle, accounting for 74% versus 47% of the contralateral eye[1]. |
别名 | INNO-8875, INO-8875, PJ875, PJ-875, INNO 8875, INNO8875, PJ 875 |
分子量 | 380.36 |
分子式 | C15H20N6O6 |
CAS No. | 871108-05-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (262.91 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.6291 mL | 13.1454 mL | 26.2909 mL | 65.7272 mL |
5 mM | 0.5258 mL | 2.6291 mL | 5.2582 mL | 13.1454 mL | |
10 mM | 0.2629 mL | 1.3145 mL | 2.6291 mL | 6.5727 mL | |
20 mM | 0.1315 mL | 0.6573 mL | 1.3145 mL | 3.2864 mL | |
50 mM | 0.0526 mL | 0.2629 mL | 0.5258 mL | 1.3145 mL | |
100 mM | 0.0263 mL | 0.1315 mL | 0.2629 mL | 0.6573 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Trabodenoson 871108-05-3 GPCR/G Protein Neuroscience Adenosine Receptor INNO-8875 INO-8875 PJ875 PJ-875 INNO 8875 INNO8875 PJ 875 Inhibitor inhibitor inhibit